INTRODUCTION
Cancers are distributed unevenly across the body. Some organs are far more likely to undergo malignant change than others, and children and adults develop very different types of cancer (Howlader et al., 2012) . This temporal and topographical bias in cancer formation can be explained in part by organ-specific susceptibilities to carcinogens or inherited oncogenic mutations; but the relative contributions of these, or other factors, to organ cancer risk is unknown (Danaei et al., 2005; Futreal et al., 2004) . A greater understanding of the processes that underlie tumorigenesis is crucial if we are to improve the prevention and treatment of cancer.
It was recently proposed that the number of stem cell divisions occurring in a tissue during life might dictate cancer risk (Tomasetti and Vogelstein, 2015) . This so-called ''bad luck'' hypothesis states that many cancers arise following the propagation of mutations that occur by chance in highly-replicative stem cell populations, rather than following exposure to environmental carcinogens. An important implication of this hypothesis is that these cancers are unavoidable and therefore resistant to primary prevention. But the notion that ''intrinsic'' factors such as stem cell replication are more important than ''extrinsic'' factors in carcinogenesis has been strongly contested (Ashford et al., 2015; Gotay et al., 2015; O'Callaghan, 2015; Potter and Prentice, 2015; Song and Giovannucci, 2015; Wild et al., 2015; Wu et al., 2016) . Indeed, recent mathematical modeling estimated that 70%-90% of the causal factors driving the most common cancers are ''extrinsic'' (Wu et al., 2016) .
The controversy surrounding these studies of cancer risk stems largely from their use of different mathematical approaches to correlate selected human cancer incidence data with variable sources and types of stem cell proliferation metrics. While these studies are important, they do not allow direct testing of the relationship between ''intrinsic'' factors such as stem cell proliferation and cancer risk and cannot account adequately for ''extrinsic'' carcinogenic factors. Experiments testing these variables directly could provide crucial insights into cancer origins but they have not been performed on an adequate scale, in appropriate experimental systems. Therefore, we performed a series of organismwide linage tracing and tumorigenesis studies, in defined populations of cells, in neonatal and adult mice, to more directly identify cell properties that dictate organ cancer risk.
RESULTS

Prom1
+ Cell Generative Capacity Varies among Organs and Developmental Stages As a first step to test the relationship between cell properties and cancer risk, we characterized the number, basal proliferation rate, and life-long generative capacity of defined cell populations across major organs in neonatal (postnatal day [P]1) and adult (P60) mice. To do this we used our Prom1 CÀL mouse that expresses both CreER2-recombinase and LacZ from the endogenous Prom1 (Cd133) locus (Zhu et al., 2009 ). We focused on Prom1 + cells because Prom1 marks a variety of cell types in mouse organs (Zhu et al., 2009) , as well as some normal and malignant human stem cells (Lee et al., 2005; O'Brien et al., 2007; Ricci-Vitiani et al., 2007; Singh et al., 2004; Yin et al., 1997) . First, a Rosa-ZsGreen Fluorescence Protein lineage tracing allele (Rosa ZsG ) was activated by tamoxifen-induced recombination in neonatal (n = 20) and adult (n = 20) Prom1 C-L ; Rosa ZsG mice.
Three days later, organs were collected from ten mice each in both age groups (''basal'' organs; Figure 1A ). The remaining mice were allowed to age for 180 days (neonatal-induced) or 600 days (adult-induced) and their organs were then collected (''aged'' organs). Bone marrow and peripheral blood samples were also taken for GFP fluorescence-activated cell sorting (FACS) of hematopoietic lineages. b-galactosidase and GFP staining detected similar numbers and distributions of Prom1 + cells in ''basal'' organs, indicating Prom1 C-L drives efficient recombination across all major organs (Figures 1B and 1F and data not shown) . The size of the Prom1 + cell population varied markedly among ''basal'' organs, ranging from the greatest in adult kidney (30.4% ± 13.3% SE) to the smallest in neonatal liver (0.4% ± 0.04% SE; Figures 1B, 1C , 1F, and 1G); however, within any given organ, the number and location of Prom1 + cells remained fairly constant between neonates and adults. We then quantified Prom1 + cell proliferative capacity by co-immunostaining ''basal'' organs with GFP and the cell proliferation marker pH3. Only limited Prom1 + proliferative capacity was detected in a handful of organs at both ages ( Figures 1D and 1E ).
To determine which organs might contain Prom1 + stem cells, we calculated the generative capacity of Prom1 + cells by measuring the difference in the proportion of GFP + cells in lineage-traced ''aged'' organs with those in the corresponding ''basal'' organ ( Figure 1A ). In select organs with high generative capacity, we also fate-mapped Prom1 + cell progeny to see if these included differentiated cells. In this manner, we showed previously that adult small intestinal Prom1 + stem cells generate the entire intestinal mucosa (Zhu et al., 2009) . Although the number and location of Prom1 + cells in each organ remained fairly constant between neonates and adults, those in neonates frequently displayed a greater generative capacity ( Figure 1H ; across all organs, p < 0.05, Wilcoxon Figure 1H ). Similarly, no GFP + cells were detected in the bone marrow or blood of ''aged'' mice (data not shown). These data are in agreement with recent reports that mouse hematopoietic stem cells cannot be isolated on the basis of Prom1 expression (Arndt et al., 2013 Figure S3 ; Table S1 ). Thus, our data reveal marked variation in the generative capacity associated with Prom1 + cells among organs and provide strong evidence that Prom1 + cells in the adult small intestine, stomach, prostate, and uterus, and the neonatal liver are stem cells. (E) Arrows identify proliferating Prom1 + cells in indicated tissues 1 day post tamoxifen. Scale bars, 10 mm.
(F and G) Direct GFP fluorescence microscopy of tissues at the indicated times post tamoxifen treatment. Whole organ direct GFP fluorescence images are also shown. Scale bars, 50 mm.
(H) Prom1 + cell-generative capacity in indicated tissues. *p < 0.05; **p < 0.005; ***p < 0.0005. Data represent mean ± SE.
See also Figures S1, S2, and S3 and Table S1 . (Futreal et al., 2004) . Mice carrying these alleles were bred with Prom1 C-L ; Rosa ZsG mice to generate a total of eight mouse lines each harboring these conditional alleles either alone or in combination ( Figure 2B ). To parallel our lineage tracing study, oncogene and TSG conditional alleles were recombined by tamoxifen treatment of neonatal (P1) and adult (P60) mice. A total of 468 mice (n = 235 neonates and 233 adults) across the eight genotypes were recombined and subjected to life-long tumor surveillance studies ( Figure 2B ). Significant differences in survival were also observed between neonatal and adult-induced mice of the same genotype ( Figure 2B ). To determine if the recombination of oncogene and TSG alleles in Prom1
+ cells induced cancer, we performed full autopsies on 166 neonatal-induced and 114 adult-induced mice that became moribund (Figures 2B-2D ; Table S2 ). Organs from all animals were inspected both macro-and microscopically for evidence of tumor formation. A total of 316 tumors were identified across the 280 autopsies. A single tumor was identified in 46% (n = 76/166) and 33% (n = 38/114) of neonatal and adultinduced mice, respectively. A further 28% (n = 46/166) of neonatal-induced and 30% (n = 34/114) of adult-induced mice contained multiple tumors (range, two to five distinct primaries; Table S2 ). Ninety-seven percent (n = 307/316) and 3% (n = 9/ 316) of all tumors were judged to be primary or metastatic, respectively, by the reviewing pathologists ( Figure 3A ; Table  S2 ). All primary and secondary tumors were GFP + ( Figure 3A ).
Primary tumors included small and large intestinal adenomas, stomach adenomas and adenocarcinomas, hepatocellular carcinomas/intrahepatic cholangiocarcinomas (HCC/ICC), hepatoblastomas, prostatic adenocarcinomas, uterine carcinomas, squamous cell skin cancers, and lung adenomas (Figures 2B-2D and 3A; Table S2 ). Few or no tumors and no premalignant lesions were found in the salivary gland, kidney, brain, or pancreas even though some of these had large populations of Prom1 + cells and would therefore have received a significant mutational burden. A total of 204 genotype-matched mice were also aged without tamoxifen induction to assess rates of spontaneous tumor formation. Only 2.5% (n = 5/204) of these mice developed tumors that were all GFP À (Table S2) . Thus, tumors in our model systems arose within recombined Prom1 + cell lineages.
Because almost one-third of mice developed multiple tumors, of which some appeared to be metastatic, we sought to more rigorously assess the accuracy of our histological diagnoses. To do this, we subjected 58 primary and 7 metastatic tumors to gene expression profiling ( Figure 3B ; Table S3 ; GEO78076). Unsupervised hierarchical clustering segregated out liver, skin, carcinomas, and adenomas. Within these clusters, tumors of the same histological type, including metastatic tumors harvested from distal sites, were co-clustered. As a further test of histologic tumor typing, we used our cross-species AGDEX algorithm (Johnson et al., 2010) to compare the transcriptomes of our mouse tumors with those of 154 histologically matched human primary cancers (Table S4 ). The transcriptomes of mouse HCC/ICC, skin squamous cell, prostate, and uterine carcinomas, and colonic adenomas closely matched those of the corresponding human tumor ( Figure 3C ). Thus, Prom1
+ cell populations in some, but not all, mouse organs are susceptible to transformation and generate cancers that recapitulate the histology and transcriptome of the corresponding human tumors.
Prom1 + Cell Transformation Is Partly Determined by Initiating Mutation
Organ bias in tumor formation in our mice could be explained in part by tissue-specific susceptibilities to initiating mutations. For example, in keeping with the high rate of WNT pathway mutations in human intestinal tumors (Bienz and Clevers, 2000) , 73% (n = 16/22) of neonatal and 91% (n = 43/47) of adultinduced mice harboring the Ctnnb1 flx(ex3) allele developed small intestinal adenomas, compared with only 13% of neonatal (n = 12/144) and 3% (n = 2/67) of adult-induced mice that lacked the allele (Figures 2B-2D and 3A; Table S2 ; Fisher's exact, p < 0.00001). Additionally, consistent with the high rate of PTEN mutations in human uterine cancer (Kong et al., 1997; Risinger et al., 1997) , 89% (n = 8/9) of female adult-induced mice carrying the Pten flx/flx allele developed uterine carcinomas versus only 5%
(n = 1/22) of adult-induced females with wild-type Pten (Fisher's exact, p < 0.0001). Different initiating mutations also induced different types of tumors within the same organ. For example, 100% (n = 5/5) of liver tumors in neonatal-induced Prom1
; Rosa ZsG ; Rosa NICD1 mice were Ctnnb1 + /Hes1 + /GS + /Sall4 + hepatoblastomas, while 100% (n = 64/64) of liver tumors arising in the other genotypes were HCC/ICC ( Figure 3A ; Table S2 ; Fisher's Table S2 . gastric adenocarcinomas, while all 37 stomach tumors arising in the other five affected genotypes were gastric adenomas; suggesting loss of Tp53 might be an important determinant of carcinoma formation in the stomach ( Figure 3A ; Table S2 ; Fisher's exact, p < 0.00005). However, initiating mutations did not fully explain the temporal and topographical bias in tumorigenesis among organs. For example, the liver, small intestine, and stomach appeared to show an age-specific bias in tumor development in the context of multiple genotypes. Therefore, we used the Cochran-Mantel-Haenszel test to determine if developmental stage and tumor prevalence in these organs were associated even when multiple genotypes were oncogenic. These analyses showed that neonatal-induced mice had a 10-fold average greater incidence of liver tumors than adult-induced mice, which was consistent across genotypes (common odds ratio [COR] P3:P60 = 9.9; Cochran-Mantel-Haenszel test [CMH] , p < 0.0005; Figures 2C and 2D ). Also consistent across genotypes, significantly more stomach tumors arose in adult than neonatal-induced mice (COR P60:P3 = 2.5, CMH, p < 0.05). Furthermore, even those organs that were susceptible to specific initiating mutations demonstrated a temporal bias in cancer formation, including small intestinal adenomas associated with Ctnnb1 activation that were more common in adult-induced mice ( Figure 2D ; Fisher's exact, p < 0.05), Pten-deleted large intestinal and lung adenomas, both of which were more common in neonatal-induced mice (Fisher's exact, p < 0.05), and perioral and perineal squamous cell carcinomas in Kras-activated/Tp53-deleted mice that were more common in neonatal-induced mice (Fisher's exact, p < 0.000005). Thus, Prom1 + cell populations in some organs were differentially susceptible to transformation independent of initiating mutation, suggesting that other cell properties might have dictated patterns of cancer development in our mice. Figure 5A ). Chronic tissue injury plays a critical role in tumorigenesis, particularly in the liver where cancer is rare in the absence of chronic tissue damage (Block et al., 2003; Coussens and Werb, 2002; Pikarsky et al., 2004) . Therefore, we next tested if Tables S3 and S4. damaging adult livers might reactivate generative and tumorigenic capacity in Prom1 + adult liver cells. Lineage tracing alleles were activated in adult Prom1 C-L mice by tamoxifen-recombination and then 3 days later their livers were damaged by either partial hepatectomy (Michalopoulos and DeFrances, 1997) or administration of diethoxycarbonyl-1,4-dihydrocollidine (DDC) (Preisegger et al., 1999) . Both damage mechanisms markedly activated Prom1 + cell proliferation and tissue repair ( Figures  5B and S1B) . Remarkably, AGDEX and GSEA analyses revealed that while the transcriptomes of Prom1 + cells isolated from Pr o 1 ro r P ad ul t tis su es ad ul t tis su es ad ul t tis su es e u s s lt ti (n = 68). All mice were subjected to tumor surveillance for at least 2 years and moribund mice underwent full autopsies (DDCtreated, n = 46; control, n = 78; Figure 5E ; Table S2 ). Liver damage dramatically increased the production of liver tumors by mutated Prom1 + cells across all genotypes (COR, DDC:control = 38.7, CMH, p < 1 3 10 À7 ; Figure 5E ). Although DDC was delivered systemically, the incidence of other cancers remained unchanged; indicating that acceleration of tumorigenesis by DDC was specific to the liver (Table S2) . Indeed, consistent rates of tumorigenesis in other organs likely explained why the survival of DDC and non-DDC mice remained relatively similar for most genotypes. For example, non-DDC-and DDC-treated Kras
G12D ;
Tp53
flx/flx mice succumbed to aggressive gastric adenocarcinomas with similar median survivals (non-DDC = 209 days; DDC = 193 days), even though all DDC-treated animals developed liver tumors. Thus, the reactivation of generative capacity in adult Prom1 + liver cells markedly increases their susceptibility to transformation, providing direct evidence that cell generative capacity can be a major determinant of organ cancer risk.
Cross-Species Analysis Predicts the Role of Recurrently Mutated Genes in Human Cancer
Because Prom1 + stem cells were peculiarly susceptible to transformation, we speculated that gene expression patterns in these cells might inform understanding of cancer, and in particular, unmask the role of genes that are recurrently mutated in cancer.
To test this, we first identified 657 genes that The Cancer Genome Atlas reported as recurrently mutated (n > 3 samples) in human hepatocellular, gastric, prostatic, or uterine carcinomas (http://www.cbioportal.org). We studied these cancers because the corresponding tumors in our mice arose from Prom1 + stem cells. Only 18% of the 657 mutated genes are validated as either oncogenes (n = 58/657) or TSGs (n = 60/ 657); the function in cancer of the remaining 82% (n = 539/657) is unknown. Next, we identified the cancers in which each gene was most and least frequently mutated, reasoning that these tissues were most and least likely to be transformed by mutations in the gene ( Figure 6A ). We then compared the log ratio of expression of each of these genes in Prom1 + versus Prom1 À cells of the corresponding tissues in mice (hereon, Prom1 + log ratio difference [LRD] ). Almost twice as many validated oncogenes (n = 42/66) than TSGs (n = 24/66) had a positive LRD, while more than twice as many TSGs (n = 36/52) than oncogenes had a negative LRD (n = 16/52; p < 0.0005; Figure 6B ). Even greater bias was observed among genes with an LRD >3 and <À3, of which almost all are oncogenes (n = 13/15) and TSGs (n = 10/11; p < 0.0005), respectively. Thus, oncogenes and TSGs of specific human cancers are expressed to relatively high and low levels, respectively, in the Prom1 + stem cells that generate these cancers in mice. Therefore, we reasoned that LRD scores might predict which of the 539 unclassified genes are oncogenes or TSGs. Fifteen percent (n = 85/539) of the unclassified genes had an LRD >3 and are therefore predicted to be oncogenes. Interestingly, these were highly enriched for regulators of immune activation (GO:0006955, false discovery rate [FDR] = 2.6 3 10 À4 ), including CD274 (PDL1) and CTLA4 that suppress T cell function and are emerging as a new class of targets of cancer immunotherapy (Pardoll, 2012) . While the functional consequences of these mutations remain unclear, PDL1 was recently demonstrated to drive T-ALL malignancies (Casey et al., 2016) ; therefore, we propose these aberrations enable early transforming stem cells to escape immunosurveillance. A further 6% (n = 34/539) of unclassified genes had an LRD <À3 and are therefore predicted to be TSGs ( Figure 6C ). These included NEFH that is hypermethylated in breast cancer (Calmon et al., 2015) and JARID2, a component of the Polycomb Repressor 2 Complex that negatively regulates hematopoietic stem cells (Kinkel et al., 2015) .
DISCUSSION
Vigorous debate has surrounded two apparently opposing explanations of why cancers are distributed unevenly among organs. One idea proposes that extrinsic carcinogens drive this bias; the other is that intrinsic factors e.g., stem cell proliferation, See also Figure S1 and Table S2 . -C9 -uterus + cells of the normal adult liver was insufficient to induce tumors; only when extrinsic damage induced these cells to proliferate were they competent to transform. Tissue damage and inflammation are well recognized determinants of cancer risk across a variety of organs, but most studies have suggested that this damage is either mutagenic e.g., through production of reactive oxygen species, or promotes the survival and proliferation of transformed cells (Coussens and Werb, 2002; Shalapour and Karin, 2015) . Our data suggest that the ''carcinogenic'' properties of some extrinsic factors might relate solely to their induction of local tissue damage and activation of stem cell repair, thereby creating an expanded population of cells that are competent for transformation. In this model, organ cancer risk could be determined by a critical combination of factors: the intrinsic proliferative capacity of the resident stem cell population, the presence of local tissue damage that expands the size of this population, the susceptibility of this population to be transformed by acquired mutations, and perhaps the presence of a stem cell transcriptome that allows the evasion of immunosurveillance. This model also allows for the scenario in which damage induces the acquisition of stem cell properties by relatively plastic cell populations ( Figure 7) . As well as determining the distribution of cancer among different organs, stem cells may also dictate temporal patterns of cancer risk within the same organ. We show on average that neonatal Prom1 + cells are far less likely to undergo transformation than those in adults with equivalent generative capacities, suggesting neonatal stem cells are intrinsically resistant to transformation. If this biology holds true in humans, then it may explain why cancer rates are many-fold lower in children than adults, despite the fact that childhood cancers accrue significant numbers of non-synonymous mutations, and organ growth rates peak in childhood (Jones and Baker, 2014; WHO Multicentre Growth Reference Study Group, 2006) . Temporal stem cell context might also dictate cancer type. For example, in our models, hepatoblastoma-a childhood-specific liver tumorwas induced only by aberrant Notch signaling in neonatal Prom1 + liver stem cells. Activation of NOTCH signaling is a recognized feature of hepatoblastoma (Ló pez-Terrada et al., 2009). Our data also suggest that transforming stem cells may do more than merely propagate mutations. Recurrently mutated We propose that extrinsic factors converge specifically on stem cells to induce mutations and/or tissue damage that provokes proliferative repair. Tissuespecific susceptibility of stem cells to induced mutations and their intrinsic, or damage-induced proliferative capacity, create a ''perfect storm'' that ultimately determines organ cancer risk. The high expression of immune regulators by stem cells might enable early transforming cells to escape immunosurveillance. See also STAR Methods.
human cancer genes that were expressed at relatively high levels in Prom1 + stem cells were strikingly enriched for immune regulators, including Ctla4 and Cd274 (Pdl1) that are targets of effective immune checkpoint inhibitors in cancer (Melero et al., 2015) . We propose that the expression of these genes enables transforming stem cells to escape immunosurveillance at the earliest stages of tumorigenesis. Further work will be required to determine the precise characteristics that render stem cells vulnerable to transformation; but these may include the tolerance of oncogenic insults that might otherwise induce cellular apoptosis or senescence. In addition to providing important insights into cancer origins, we identify a number of new Prom1 + stem cell populations in several mouse organs including the neonatal and damaged adult liver, stomach, uterus, and prostate. At least two populations of well-characterized stem cells are known to exist in the adult mouse liver: peri-central vein Axin2 + hepatocytes that constantly regenerate undamaged liver (Wang et al., 2015) and damageinduced, peri-portal Lgr5 + cells that repair the liver (Huch et al., 2013 differed little between neonates and adults (e.g., lung). Therefore, it will be important to determine if neonatal Prom1 + cells in these organs also give rise to quiescent but reparative and tumorigenic Prom1 + cells in adults. The various cancer models described here display remarkable histological and transcriptomic similarities to the corresponding human diseases and should therefore add significantly to the existing armamentarium of mouse cancer models available for biology and therapeutic studies. A number of organs in our mice generated few or no cancers (e.g., salivary gland, pancreas, and kidney) even though these tissues contained large numbers of Prom1 + cells and can be transformed by the same oncogenes and TSGs used in our study (Clark et al., 2011; Hingorani et al., 2005; Raimondi et al., 2006) . Our hypothesis proposes that these tissues did not develop cancer because they lacked Prom1 + stem cells; however, because many of our mice developed multiple tumors, it is possible that cancers with shorter latencies arose and killed mice before they could develop salivary gland, pancreatic, or kidney tumors. Although feasible, we believe this is unlikely because the median survival of mice harboring activated Kras and Ctnnb1 alleles in our study was equal to or greater than the published latency of salivary gland, pancreatic, and kidney cancers in mouse models driven by these alleles. In summary, our data provide direct experimental evidence that the mutation of stem cells is an important determinant of cancer risk. We propose that extrinsic factors converge on these cell populations, inducing mutations and/or proliferation that together create the conditions necessary to drive tumorigenesis.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagents may be directed to, and will be fulfilled by the corresponding author Richard J. Gilbertson (richard.gilbertson@cruk.cam.ac.uk) .
EXPERIMENTAL MODEL AND SUBJECT DETAILS Mice
Mice were Prom1 C-L (Zhu et al., 2009) 
METHOD DETAILS Mouse and Tissue Handling
Cre-recombination in mice was activated with 3mg tamoxifen (TMX)/40 g body weight at either neonatal (P1) or adult (typically P60) for two consecutive days by IP injection. Liver damage was induced in mice by partial hepatectomy or chow containing 0.1% DDC (Bio-Serv) commenced 3 days post TMX. Mouse prostate regeneration was induced by orchidectomy and serial testosterone implants. See below for detailed surgical procedures. Full-body necropsy was performed on moribund mice, or the indicated time point, whichever first. Tissue sections of all major mouse organs were subjected to direct GFP microscopy and b-galactosidase staining using 12 mm frozen sections or H&E and appropriate diagnostic immunostaining performed on 5 mm paraffin sections.
Immunohistochemistry and Immunofluorescence
For immunohistochemistry, tissues were fixed in 4% paraformaldehyde, paraffin embedded and sectioned at 5 mm. Antibodies for immunohistochemical staining ( Figure 3A ) include anti-b-catenin, anti-Glutamine Synthetase, anti-Hes-1, anti-Sall4, anti-Krt19 and anti-HepPar-1. For GFP microscopy and immunofluorescence, tissues were perfused and fixed in 2% paraformaldehyde, cryo-protected, frozen in OCT and sectioned at 12 mm. Antibodies for immunofluorescence staining ( Figures S1 and S2 ) include anti-phospho Histone H3, anti-androgen receptor, anti-p63, anti-A6, anti-Krt19, and anti-HNF4a. Lectins for gastric mucosa staining ( Figure S2 ) include rhodamine-labeled DBA, rhodamine-labeled UEA I, GS II, Alexa Fluorâ 594 conjugate. See ''Key Resources Table' ' for details.
Orchidectomy and Testosterone Implantation Two-month-old male Prom1 C-L ; Rosa ZsG mice were castrated 3 days post tamoxifen treatment using standard techniques. Briefly, each mouse was anesthetized with 2%-3% isoflurane. A small incision was made rostral to the scrotal sac and gentle pressure applied to aid visualizing the testicles. The tunica albuginea was incised to separate and remove the testes from the scrotal ligament. Skin edges were adhered with tissue glue. Mice were allowed to rest for four weeks to ensure involution of the prostate prior to insertion of subcutaneous testosterone pellet implantation. Mice were anesthetized with 2%-3% isoflurane and a small skin incision made on the dorsal neck. A testosterone pellet (testosterone-propionate, 2.5 mg/pellet, 21-day release, Innovative Research of America) was inserted and placed 2 cm from the incision by a trochar (Innovative Research of America, . Tissue glue was used to close the skin edges. The procedure was repeated four times every eight weeks to induce repeated prostatic involution and regeneration that was monitored by ultrasound imaging.
Partial Hepatectomy
Partial hepatectomy in two month old Prom1 CreERT2 ; Rosa LacZ mice was performed 3 days post tamoxifen treatment using standard techniques (Boyce and Harrison, 2008) . Briefly, each mouse was anesthetized with 2%-3% isoflurane and a transverse abdominal incision made to expose the posterior section of the median lobe of the liver. The left and right median lobes of the liver were surgically removed. Sutures used to ligate the hepatic vessels and close the abdominal wall. Wound clips were used to close the skin.
Ultrasound Scans of Prostate
Mice were anesthetized with 2%-3% isofluorane in O 2 (2 l/min) and their hair removed from the lower ventral abdomen. Animals were then positioned ventrally and secured on the heated platform, allowing physiological monitoring throughout. Warmed Aquasonic 100 (Parker Laboratories) coupling gel was applied to the surface of the skin and target organs imaged (40 MHz) using a VEVO-770 High Resolution Ultrasound system (FujiFilm VisualSonics). Data were acquired with an in-plane resolution of 40 mm and a step-size of 0.102 mm and processed using the VEVO-770 software to provide volumetric information and rendering.
Two-Photon Laser-Scanning Microscopy Two-photon laser-scanning microscopy was performed using an Ultima imaging system (Prairie Technologies), a Ti:sapphire Chameleon Ultra femtosecond-pulsed laser (930 nm) (Coherent), and a 20 3 0.95 NA water-immersion IR objective (Olympus). Stacks of images were reconstructed in 3D using Imaris software (Bitplane).
Single Cells Isolation from Mouse Organs
Liver was dissociated in situ with Liberase-TM (0.1 U/ml; Roche) in Krebs' Ringer with glucose (3.6 g/L) and calcium (1 mM) as described (Shupe et al., 2009) . Prostates were dissociated with 800 mg/ml collagenase type I (Worthington) and 100 mg/ml DNase I (Roche) in DMEM (Lonza) supplemented with 2mM L-glutamine (Invitrogen), 100 U/ml penicillin, 100 mg/ml streptomycin (Invitrogen) and 10% fetal bovine serum (Atlanta Biologicals) at 37 C for 90 min as described (Xin et al., 2003) . Stomachs were removed from 20 mice, opened, and washed extensively in PBS. The mucosa was scraped off the pyloric region and digested for 60 min at 37 in 0.1% Pronase (Roche) and 100 mg/ml DNase I (Roche) in PBS containing 2% BSA and 1mM EDTA as described (Houghton et al., 2004) .
Uteruses were dissociated with 0.2% collagenase type I (Worthington) and 100 mg/ml DNase I (Roche) in DMEM (Lonza) supplemented with 2 mM L-glutamine (Invitrogen), 100 U/ml penicillin, 100 mg/ml streptomycin (Invitrogen) and 10% fetal bovine serum (Atlanta Biologicals) at 37 C for 90 min as described (Masuda et al., 2007) . Salivary glands and kidneys were digested with 20 U/ml Papain (Sigma) and 100 mg/ml DNase I (Roche) in DMEM (Lonza) supplemented with 2 mM L-glutamine (Invitrogen), 100 U/ml penicillin, 100 mg/ml streptomycin (Invitrogen) and 10% fetal bovine serum (Atlanta Biologicals) at 37 C for 30-60 min.
QUANTIFICATION AND STATISTICAL ANALYSIS
Quantification of Prom1 + cell population size, proliferative capacity, and generative capacity was performed on multiple tissue sections gathered from 10 separate mice.
Where appropriate, Figure Legends define the statistical test and associated parameters used to analyse data displayed in the corresponding Figure. Data are judged to be statistically significant when p < 0.05 in applied statistical analysis. In Figures 1  and 6 , asterisks denote statistical significance (*, p < 0.05; **, p < 0.01; ***, p < 0.001).
Quantification of Prom1
+ Cell Characteristics Prom1 + cell population size, Prom1 + cell proliferative capacity, Prom1 + cell generative capacity and global organ proliferative capacity were quantified using frozen tissue sections of the appropriate organs taken from Prom1 C-L/+ ; Rosa ZsG mice that had undergone tamoxifen recombination as described. For each analysis, 12 mm frozen sections were prepared from three separate and representative areas of each organ from a minimum of 10 individual Prom1
; Rosa ZsG mice at each time point ('basal' and 'aged' organs, 30 sections each per organ per time point). For assessments of Prom1 + cell population size, sections were subjected to b-galactosidase staining and counterstained with nuclear fast red (Vector Laboratories). The Prom1 + cell population size was then calculated as the average percentage of b-galactosidase + nuclei per total nuclei in each organ by counting a minimum of $15,000 nuclei across the 30 sections of each organ. Note, because different organs display significantly different macro-and microscopic morphologies, including wide variations in cellular density and nuclear size, we did not employ automated imaging software to count cells but performed all counts manually.
We took a very similar approach to calculate Prom1 + cell proliferative capacity, although frozen sections were subjected to pH3 and GFP co-immunofluorescence as described above and counterstained with DAPI (Vector Laboratories were extracted using PicoPure RNA extraction kit (Arcturus). mRNA expression profiles were generated using Affymetrix HT430 (mouse) array. Gene expression data were summarized and normalized using the RMA method as implemented in Partek Genomics Suite 6.6. The data were then imported into Spotfire Decision Site for Unsupervised Gene Hierarchical Clustering. Differences in gene expression between defined groups were calculated using a series of Welch t tests with a Bonferroni threshold at 0.05%. The agreement of differential expression (AGDEX) procedure was performed exactly as described previously (Johnson et al., 2010) , and gene set enrichment analyses (GSEA) was performed using the online analytical resource from the Broad Institute (http://www. broadinstitute.org/gsea/index.jsp). 
Statistical Modeling
